Company number 08505543
Status Active
Incorporation Date 26 April 2013
Company Type Private Limited Company
Address 7 REGENTS DRIVE, PRUDHOE, NORTHUMBERLAND, NE42 6PX
Home Country United Kingdom
Nature of Business 64204 - Activities of distribution holding companies
Phone, email, etc
Since the company registration twenty-five events have happened. The last three records are Appointment of Mr David Horry as a director on 24 May 2017; Group of companies' accounts made up to 31 March 2016; Confirmation statement made on 30 September 2016 with updates. The most likely internet sites of CONVERSE PHARMA LIMITED are www.conversepharma.co.uk, and www.converse-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is twelve years and eight months. The distance to to Prudhoe Rail Station is 1.1 miles; to Blaydon Rail Station is 5 miles; to Riding Mill Rail Station is 5.5 miles; to Newcastle Airport Metro is 6.7 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Converse Pharma Limited is a Private Limited Company.
The company registration number is 08505543. Converse Pharma Limited has been working since 26 April 2013.
The present status of the company is Active. The registered address of Converse Pharma Limited is 7 Regents Drive Prudhoe Northumberland Ne42 6px. . GULLIFORD, Mark James is a Director of the company. HORRY, David is a Director of the company. WILSON, Derek Andrew is a Director of the company. MAWDSLEYS GROUP INVESTMENTS LIMITED is a Director of the company. Director WELCH, Christopher has been resigned. The company operates in "Activities of distribution holding companies".
Current Directors
Director
MAWDSLEYS GROUP INVESTMENTS LIMITED
Appointed Date: 18 October 2013
Resigned Directors
Persons With Significant Control
Mr Mark James Gulliford
Notified on: 30 September 2016
56 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%
Mr Derek Andrew Wilson
Notified on: 30 September 2016
61 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%
CONVERSE PHARMA LIMITED Events
26 May 2017
Appointment of Mr David Horry as a director on 24 May 2017
10 Jan 2017
Group of companies' accounts made up to 31 March 2016
07 Oct 2016
Confirmation statement made on 30 September 2016 with updates
08 Sep 2016
Satisfaction of charge 085055430001 in full
30 Dec 2015
Group of companies' accounts made up to 31 March 2015
...
... and 15 more events
23 Oct 2013
Registration of charge 085055430001
24 May 2013
Termination of appointment of Christopher Welch as a director
24 May 2013
Appointment of Mr Derek Andrew Wilson as a director
24 May 2013
Appointment of Mr Mark James Gulliford as a director
26 Apr 2013
Incorporation
18 October 2013
Charge code 0850 5543 0005
Delivered: 24 October 2013
Status: Outstanding
Persons entitled: Rbs Invoice Finance Limited
Description: Notification of addition to or amendment of charge…
18 October 2013
Charge code 0850 5543 0004
Delivered: 24 October 2013
Status: Outstanding
Persons entitled: Rbs Invoice Finance Limited
Description: Notification of addition to or amendment of charge…
18 October 2013
Charge code 0850 5543 0003
Delivered: 24 October 2013
Status: Outstanding
Persons entitled: Rbs Invoice Finance Limited
Description: Notification of addition to or amendment of charge…
18 October 2013
Charge code 0850 5543 0002
Delivered: 24 October 2013
Status: Outstanding
Persons entitled: The Royal Bank of Scotland PLC
Description: Notification of addition to or amendment of charge…
18 October 2013
Charge code 0850 5543 0001
Delivered: 23 October 2013
Status: Satisfied
on 8 September 2016
Persons entitled: Mawdsleys Group Investments Limited
Description: Notification of addition to or amendment of charge…